ArticleOncogene2019

Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target.

E M M Abdelwahab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.